The Addition Of Carfilzomib To A Lenalidomide-Based Triplet Improves Outcomes In Newly Diagnosed Transplant Eligible Myeloma Patients With Renal Impairment: A Subgroup Analysis Of The Myeloma Xi Trial
BLOOD(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要